Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials
Randomized controlled trials of interventions to improve adherence to antiretroviral medications are not always feasible. Marginal structural models (MSM) are a statistical methodology that aims to replicate the findings of randomized controlled trials using observational data. Under the assumption...
Saved in:
Published in: | Journal of acquired immune deficiency syndromes (1999) Vol. 43 Suppl 1; no. Supplement 1; pp. S96 - S103 |
---|---|
Main Authors: | , , , |
Format: | Journal Article Conference Proceeding |
Language: | English |
Published: |
Hagerstown, MD
Lippincott Williams & Wilkins, Inc
01-12-2006
Lippincott Williams & Wilkins |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Randomized controlled trials of interventions to improve adherence to antiretroviral medications are not always feasible. Marginal structural models (MSM) are a statistical methodology that aims to replicate the findings of randomized controlled trials using observational data. Under the assumption of no unmeasured confounders, 3 MSM estimators are available to estimate the causal effect of an intervention. Two of these estimators, G-computation and inverse probability of treatment weighted (IPTW), can be implemented using standard software. G-computation relies on fitting a multivariable regression of adherence on the intervention and confounders. Thus, it is related to the standard multivariable regression approach to estimating causal effects. In contrast, IPTW relies on fitting a multivariable logistic regression of the intervention on confounders. This article reviews the implementation of these methods, the assumptions underlying them, and interpretation of results. Findings are illustrated with a theoretic data example in which MSM are used to estimate the effect of a behavioral intervention on adherence to antiretroviral therapy. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1525-4135 1944-7884 |
DOI: | 10.1097/01.qai.0000248344.95135.8d |